Showing results (591-600 of 3,072) with videos related to
Sort By:
Pageof 308
Chemotherapy|January 25, 2014
Gefitinib enhances the antitumor activity of CPT-11 in vitro and in vivo by inhibiting ABCG2 but not ABCB1: a new clue to circumvent gastrointestinal toxicity riskYutaka Inoue, Yoji Ikegami, Kazumi Sano, et al.Chemotherapy|January 1, 1979
Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporinS Ripa, M PrennaChemotherapy|January 1, 1978
Binding of chloramphenicol and its acetylated derivatives to Escherichia coli ribosomal subunitsJ C Piffaretti, Y FromentChemotherapy|March 28, 2021
Animal Hosts and Experimental Models of SARS-CoV-2 InfectionCristina Parolin, Sara Virtuoso, Marta Giovanetti, et al.Chemotherapy|August 24, 2020
Further Analytical, Pharmacokinetic, and Clinical Observations on Low-Dose Ponatinib in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaPierantonio Menna, Ugo De Grazia, Francesco Marchesi, et al.Chemotherapy|January 1, 1988
Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistanceW Cullmann, W Dick, M Stieglitz, et al.Chemotherapy|May 25, 2006
Chloroquine-resistant Plasmodium falciparum local strain in Taiz Governorate, Republic of YemenHussien O Alkadi, Mohamed T Al-Maktari, Majed A NoomanChemotherapy|January 1, 1991
Variation in induction of chromosomal beta-lactamase expression in strains of Enterobacter cloacaeJ Stoorvogel, M H van Gestel, P A Ketelaar-van Gaalen, et al.Chemotherapy|January 1, 1991
Turbidimetric study of the effect of inoculum density on the response of Escherichia coli to gentamicin under aerobic and anaerobic conditionsR Edwards, J Brown, D GreenwoodChemotherapy|January 1, 1991
Influence of human urine on the in vitro activity and postantibiotic effect of ciprofloxacin against Escherichia coliG G Zhanel, J A Karlowsky, R J Davidson, et al.Pageof 308